Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
14 hedge funds and large institutions have $1.61M invested in Acer Therapeutics Inc in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
27% more funds holding
Funds holding: 11 → 14 (+3)
13% less capital invested
Capital invested by funds: $1.86M → $1.61M (-$246K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$119K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$92.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$19.3K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$798 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$38K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $630K | +$119K | +2,841 | +18% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $547K | +$20.3K | +484 | +3% |
|
3
California Public Employees Retirement System
Sacramento,
California
| $215K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $115K | – | – | – |
|
|
VKH
5
Virtu KCG Holdings
New York
| $73K | +$92.7K | +2,208 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $15K | +$19.3K | +459 | New |
|
7
Creative Planning
Overland Park,
Kansas
| $7K | – | – | – |
|
|
BFA
8
BlackRock Fund Advisors
San Francisco,
California
| $6K | +$798 | +19 | +11% |
|
9
Morgan Stanley
New York
| $2K | +$126 | +3 | +6% |
|
|
JWA
10
JFS Wealth Advisors
Hermitage,
Pennsylvania
| $1K | – | – | – |
|
|
AIM
11
Acrospire Investment Management
Chicago,
Illinois
| – | -$38K | -883 | Closed |
|
12
Bank of America
Charlotte,
North Carolina
| – | +$42 | +1 | New |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| – | +$168 | +4 | New |
|
ACER Hedge Fund Activity: Q3 2016 in Review
14 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q3 2016, worth a combined $1.61M — down 13% from $1.86M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ACER positions and 1 closed out — a net gain of 3 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $119K. The largest seller was Acrospire Investment Management, exiting entirely with an estimated $38K sold.
- 14 institutional investors held Acer Therapeutics Inc (ACER) as of Q3 2016, up from 11 in Q2 2016.
- Funds reported $1.61M of Acer Therapeutics Inc stock for Q3 2016, down 13% quarter-over-quarter.
- 4 funds opened new Acer Therapeutics Inc positions in Q3 2016 and 1 closed out, a net change of +3 holders.
- The largest Acer Therapeutics Inc buyer in Q3 2016 was Renaissance Technologies, an estimated $119K added.
- The largest Acer Therapeutics Inc seller in Q3 2016 was Acrospire Investment Management, an estimated $38K sold.
Based on aggregated 13F filings for Q3 2016.